Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Yangzhou
Clinical trial register · China

Clinical Trials in Yangzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 09 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Beijing 5576 Shanghai 3879 Guangzhou 3345 Hangzhou 1819 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Northern Jiangsu People's Hospital23 Fudan University5 Zhuan Zhang4 Second Affiliated Hospital, Zhejiang University, School of Medicine3 Jiangsu Taizhou People's Hospital2
Site location
Beijing5576 Shanghai3879 Guangzhou3345 Hangzhou1819 Wuhan1343
All 625 locations
Target enrolment
to

Trials with a site in Yangzhou

56 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
The Second Hospital of Anhui Medical University
Not applicable
440
Hefei, Huai'an, Yangzhou
2027-01
Not yet open
Central South University
Not applicable
75
Fuzhou, Changsha, Yangzhou
2026-10-25
Recruiting
Effect of Laparoscopic Hepatectomy Combined With Splenectomy on Hepatic Functional Reserve and Immune Function
NCT07811687Liver Cirrhosis, HCC - Hepatocellular Carcinoma, Hypersplenism
Northern Jiangsu People's Hospital
Observational
30
Yangzhou
2026-08-02
Recruiting
Jiangsu Taizhou People's Hospital
Not applicable
1,356
Yancheng, Yangzhou, Xuzhou
2026-07-26
Recruiting
Jiangsu Taizhou People's Hospital
Not applicable
942
Yancheng, Yangzhou, Xuzhou
2026-07-26
Not yet open
Northern Jiangsu People's Hospital
Observational
140
Yangzhou
2026-06-01
Not yet open
Effect of LSD on Lipid Profiles in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)
NCT07588334Cirrhosis, Liver, Splenectomy; Status, Portal Hypertension, Lipid Profiles
Northern Jiangsu People's Hospital
Observational
30
Yangzhou
2026-05-01
Not yet open
Effect of Laparoscopic Splenectomy on Renal Function in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up)
NCT07585773Cirrhosis, Splenectomy; Status, Hypersplenism, Kidney Function Issue
Northern Jiangsu People's Hospital
Observational
30
Yangzhou
2026-05-01
Not yet open
Effect of Laparoscopic Splenectomy on Lipid Profiles in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up)
NCT07588373Cirrhosis, Splenectomy; Status, Hypersplenism, Lipid Profiles
Northern Jiangsu People's Hospital
Observational
30
Yangzhou
2026-05-01
Recruiting
Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS
NCT07461545Cirrhosis, Splenectomy, Portal Vein Thrombosis, Hypertension, Portal
DrugApixaban
Northern Jiangsu People's Hospital
Not applicable
20
Yangzhou
2026-04-01
Recruiting
Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD
NCT07461532Cirrhosis, Splenectomy, Portal Vein Thrombosis, Hypertension, Portal
DrugApixaban
Northern Jiangsu People's Hospital
Not applicable
20
Yangzhou
2026-04-01
Recruiting
Vagus Nerve-guided Laparoscopic Splenectomy and Azygoportal Disconnection
NCT07462091Cirrhosis, Hypersplenism, Hypertension, Portal
Northern Jiangsu People's Hospital
Not applicable
15
Yangzhou
2026-03-25
Recruiting
Northern Jiangsu People's Hospital
Phase 4
336
Yangzhou
2026-03-02
Recruiting
Effect of Esketamine on Postoperative Sleep in Postmenopausal Women
NCT07315074Circadian Rhythm, Postoperative Sleep Disturbance
DrugEsketamine
Zhuan Zhang
Not applicable
164
Jingjiang, Yangzhou
2026-03-01
Not yet open
Northern Jiangsu People's Hospital
Not applicable
300
Yangzhou
2026-02-01
Recruiting
Northern Jiangsu People's Hospital
Observational
50
Yangzhou
2026-01-07
Recruiting
Northern Jiangsu People's Hospital
Phase 2
30
Yangzhou
2025-11-01
Recruiting
Laparoscopic Partial Splenectomy for Hypersplenism in Liver Cirrhosis Patients
NCT07205471Cirrhoses, Liver, Splenectomy; Status, Partial
Northern Jiangsu People's Hospital
Not applicable
30
Yangzhou
2025-09-24
Recruiting
Northern Jiangsu People's Hospital
Phase 2
30
Yangzhou
2025-09-01
Recruiting
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
NCT07005154Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer
DrugsPRL-02·Abiraterone acetate·Prednisolone·Prednisone
Astellas Pharma Global Development, Inc.
Phase 2
218
Yangzhou, Tianjin, Hangzhou, Huaian, Shanghai
2025-08-19
Recruiting
China National Center for Cardiovascular Diseases
Not applicable
4,900
Hefei, Beijing, Shenzhen, Shijiazhuang, Luoyang, Zhengzhou, Nanjing, Yangzhou
2025-08-08
Recruiting
Northern Jiangsu People's Hospital
Not applicable
300
Yangzhou
2025-08-01
Recruiting
Northern Jiangsu People's Hospital
Phase 2
20
Yangzhou
2025-08-01
Recruiting
Clinical Study on Laparoscopic Resection of Splenic Artery Aneurysm With Preservation of Spleen
NCT07053605Splenic Artery Aneurysm, Immune Function, Hemodynamics
Northern Jiangsu People's Hospital
Not applicable
10
Yangzhou
2025-06-23
Active, closed
A Study of SGB-9768 in Patients With Complement-mediated Kidney Diseases
NCT06786338IgA Nephropathy (IgAN), C3 Glomerulopathy, IC-MPGN
DrugSGB-9768
Suzhou Sanegene Bio Inc.
Phase 2
45
Beijing, Changsha, Chengdu, Guiyang, Hangzhou, Shanghai, Yangzhou, Yinchuan
2025-06-06
Not yet open
Effect of ADT and ARPI on Bone Loss of Patients with Prostate Cancer
NCT06838520Prostate Cancer (Adenocarcinoma)
The First Affiliated Hospital with Nanjing Medical University
Observational
200
Changzhou, Nanjing, Suzhou, Yangzhou
2025-04-01
Active, closed
Northern Jiangsu People's Hospital
Not applicable
190
Yangzhou
2025-03-16
Not yet open
Nanjing Broad Biopharmaceutical Ltd.
Observational
300
Huaian, Suzhou, Xuzhou, Yangzhou
2025-03-01
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
38
Yangzhou, Shanghai, Hangzhou, Huzhou, Jiaxing, Ningbo, Wenzhou
2025-01-06
Not yet open
Daorong Wang
Not applicable
50
Yangzhou
2025-01-01
Not yet open
Subei People's Hospital of Jiangsu Province
Not applicable
238
Yangzhou
2025-01-01
By invitation
Multicenter Prospective Cohort Study of Hypertriglyceridemia Acute Pancreatitis
NCT06976099Acute Pancreatitis (AP), Hypertriglyceridemia Acute Pancreatitis
Peking Union Medical College Hospital
Observational
1,000
Beijing, Guangzhou, Zunyi, Harbin, Changsha, Nanjing, Yangzhou, Dalian
2024-11-13
Recruiting
Venous Congestion And Cognitive Dysfunction After Cardiac Surgery
NCT07483151Intraoperative Venous Congestion And Cognitive Dysfunction After Cardiac Surgery
Zhuan Zhang
Observational
110
Yangzhou
2024-11-01
Active, closed
Cola Ingestion for Esophageal Bolus Impaction
NCT06652620Esophageal Cancer
Fudan University
Not applicable
50
Xiamen, Anyang, Yangzhou, Jingdezhen, Shanghai
2024-11-01
Recruiting
Venous Congestion And Delirium After Cardiac Surgery
NCT07285187Intraoperative, Venous Congestion, Postoperative Delirium (POD), Cardiac Surgery
Zhuan Zhang
Observational
120
Yangzhou
2024-11-01
Recruiting
Fudan University
Phase 4
756
Harbin, Changzhou, Nanjing, Yangzhou, Shanghai, Hangzhou, Ningbo
2024-10-18
Recruiting
Venous Congestion and Cardiac Surgery-Associated Acute Kidney Injury
NCT07232277Intraoperative, Venous Congestion, Cardiac Surgery-associated Acute Kidney Injury
Zhuan Zhang
Observational
114
Yangzhou
2024-10-15
Active, closed
Northern Jiangsu People's Hospital
Not applicable
376
Yangzhou
2024-10-10
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
5,500
Guangzhou, Wuhan, Yangzhou, Shenyang, Chengdu, Hangzhou
2024-08-01
Recruiting
Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease
NCT05387031Crohn Disease, Stricture; Bowel, Intestinal Stricture
DrugUstekinumab
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
239
Beijing, Chongqing, Guangzhou, Huai'an, Suzhou, Yangzhou, Hangzhou
2024-08-01
Active, closed
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
DrugTarlatamab
Amgen
Phase 3
404
Beijing, Chongqing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Yangzhou
2024-02-20
Active, closed
Summit Therapeutics
Phase 3
1,600
Yangzhou, Tongzhou, Fuzhou, Lanzhou, Guangzhou, Nanning, Haikou, Shijiazhuang
2023-10-26
Not yet open
Fudan University
Phase 4
384
Shijiazhuang, Zhengzhou, Changsha, Nantong, Yangzhou, Shanghai, Hangzhou, Jiaxin
2023-10
Recruiting
Fudan University
Phase 3
764
Beijing, Chongqing, Fuzhou, Guangzhou, Guangdong, Nantong, Yangzhou, Shenyang
2023-06-20
Recruiting
Fudan University
Phase 3
766
Beijing, Chongqing, Fuzhou, Guangzhou, Guangdong, Nantong, Yangzhou, Shenyang
2023-06-01
Active, closed
AstraZeneca
Phase 3
37
Beijing, Chongqing, Yangzhou, Zhengzhou
2023-05-08
Recruiting
China-Japan Friendship Hospital
Phase 4
336
Beijing, Baoding, Qinhuangdao, Gongyi, Yangzhou, Jining, Qingdao, Changzhi
2023-03-29
Recruiting
Remimazolam for Postoperative Atrial Fibrillation
NCT05891145Coronary Artery Bypass Grafting, Remimazolam
DrugsRemimazolam·Midazolam
Yangzhou University
Not applicable
50
Yangzhou
2023-02-01
Recruiting
Shanghai Zhongshan Hospital
Observational
6,000
Xiamen, Guangzhou, Zhengzhou, Wuhan, Jiangyin, Wuxi, Yangzhou, Yixing
2022-05-01
Recruiting
CT-guided Localization for Micro Hepatocellular Carcinoma Before Surgical Resection
NCT05433467Cirrhosis, Liver, Hepatocellular Carcinoma
Northern Jiangsu People's Hospital
Not applicable
5
Yangzhou
2022-05-01
Recruiting
Singlera Genomics Inc.
Observational
80,000
Yangzhou
2022-04-01
Recruiting
Northern Jiangsu People's Hospital
Not applicable
20
Yangzhou
2022-03-01
Recruiting
Northern Jiangsu People's Hospital
Not applicable
20
Yangzhou
2022-03-01
Recruiting
Northern Jiangsu People's Hospital
Not applicable
20
Yangzhou
2022-03-01
Recruiting
National Research Institute for Family Planning, China
Observational
20,000
Zhongshan, Zhangjiakou, Daqing, Changzhou, Yangzhou, Hohhot, Qingdao, Zaozhuang
2019-06-01
Recruiting
Xi Shan Wang
Observational
3,060
Shijiazhuang, Harbin, Wuhan, Changsha, Changzhou, Xuzhou, Yangzhou, Anshan
2018-11-02
Rows per page Showing 1–56 of 56
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 November 2026. https://priyalifescience.com/clinical-trials-china/city/yangzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 09 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 56 of those studies with a site in Yangzhou.

How many clinical trials are recruiting in Yangzhou?

36 of the 56 studies on this page are recruiting new participants as of the 09 Nov 2026, 03:17 UTC sync. A further 12 have not yet opened recruitment, 7 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Yangzhou), 56 studies
PhaseStudiesRecruitingShare
Not applicable231541.1%
Observational181132.1%
Phase 26510.7%
Phase 3528.9%
Phase 4437.1%

Most active sponsors

Lead sponsors with the most studies (Yangzhou)
Lead sponsorStudiesRecruiting
Northern Jiangsu People's Hospital2316
Fudan University53
Zhuan Zhang44
Second Affiliated Hospital, Zhejiang University, School of Medicine33
Jiangsu Taizhou People's Hospital22
Amgen10
Astellas Pharma Global Development, Inc.11
AstraZeneca10
Central South University10
China National Center for Cardiovascular Diseases11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.